Guardian Bio
YC S22Boston, US · Founded 2022 · 2 employees · 1 known investors
Guardian Bio develops dendritic cell therapy for solid tumors by generating cDC1 cells from patient stem cells to restore immune function in cancer treatment. The company targets late-stage cancer patients who have dysfunctional antigen presentation.
Also known as GuardianBio
BiotechHealthtechMedical DevicesHealthcareTherapeuticsOncologyUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S22)
Guardian Bio was founded in 2022 by Ananya Zutshi, Ricky Barrett, and Dr. Palucka.
AZ
Ananya ZutshiinCo-FounderShe holds a Bachelor of Science in Engineering from Duke University and a Master's degree in Engineering plus an MBA from Harvard University, with professional experience in pharmaceutical and biotech operations, engineering, project management, and early-stage investing.
RB
Ricky BarrettinCo-Founder and CSO / COO2022–2025He began his career as a marine biologist and research diver at Florida Atlantic University studying marine natural products and drug discovery, then earned a PhD in immunology from UCF and completed a postdoctoral fellowship in cancer immunology and tumor microenvironment at the University of Pennsylvania.
DP
Dr. PaluckaAcademic Co-Founder, Chair, Scientific Advisory Board
Investors · 1
Competitors · 4
by search overlap
bio11 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Guardant Health9 shared keywordsGuardant Health develops blood-based testing (liquid biopsy) for cancer detection and monitoring across all stages of the disease. The company serves oncologists, patients, and biopharmaceutical firms with FDA-approved tests for cancer screening, early-stage risk assessment, and treatment selection.
iOrganBio8 shared keywordsiOrganBio builds CellForge, an AI- and automation-driven platform for engineering and manufacturing human cells and organoids.
Orca Bio7 shared keywordsOrca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.
Companies competing with Guardian Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Guardian Bio do?
- Guardian Bio develops dendritic cell therapy for solid tumors by generating cDC1 cells from patient stem cells to restore immune function in cancer treatment. The company targets late-stage cancer patients who have dysfunctional antigen presentation.
- Who founded Guardian Bio?
- Guardian Bio was founded by Ananya Zutshi, Ricky Barrett, Dr. Palucka in 2022.
- Who are Guardian Bio's investors?
- Guardian Bio's investors include Y Combinator.
- Where is Guardian Bio headquartered?
- Guardian Bio is headquartered in Boston, US.